MEDICINES CONTROL COUNCIL
|
|
|
- Reginald Weaver
- 5 years ago
- Views:
Transcription
1 Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 06/1.3/04 MC PHARMA (PTY) THIANIL/TREXONIL COMBIPACK Each pack contains: THIANIL VIAL containing: THIAFENTANIL OXALATE 10,0 mg/1,0 ml TREXONIL VIAL containing: NALTREXONE HYDROCHLORIDE /1,0 ml 06/1.3/05 MC PHARMA (PTY) TREXONIL Each vial contains: NALTREXONE HYDROCHLORIDE /1,0 ml 06/1.3/06 MC PHARMA (PTY) THIANIL Each vial contains: THIAFENTANIL OXALATE 10,0 mg/1,0 ml 34/21.5.1/0343 SCHERING-PLOUGH (PTY) 34/21.5.1/0344 SCHERING-PLOUGH (PTY) 37/5.8/0139 JOHNSON & JOHNSON (PTY) ASMANEX TWISTHALER 200 µg ASMANEX TWISTHALER 400 µg SINUTAB SINUS PAIN EXTRA STRENGTH Each inhalation delivers: MOMETASONE FUROATE 200,0 µg Each inhalation delivers: MOMETASONE FUROATE 400,0 µg PARACETAMOL 500,0 mg PSEUDOEPHEDRINE HYDROCHLORIDE 30,0 mg CHLORPHENIRAMINE MALEATE 2,0 mg CODEINE PHOSPHATE 10,0 mg 38/11.5/0166 PHARMACARE AGAROL LACTULOSE Each 5,0 ml syrup contains: LACTULOSE 3,3 mg 38/2.7/0261 WYETH S.A. (PTY) ADVIL LIQUI-GEL 400 IBUPROFEN 400,0 mg Notification of Aug09v1.doc September 2009 Page 1 of 5
2 Notification of of Medicines A39/3.2/0352 A39/30.3/0591 A39/30.3/0592 A39/30.3/0593 A39/34/0647 A40/5.10/0323 A40/5.10/0324 A40/5.10/0325 A40/2.6.5/0527 A40/2.6.5/0528 A40/2.6.5/0529 A40/26/0609 A40/26/0610 A40/26/0611 PHARMACO DISTRIBUTION (PTY) ASTELLAS PHARMA (PTY) SUPLASYN 250 I.U. 500 I.U I.U. PROGRAF 0,5 mg SABAX COVAN PROPAN RESKIT 0,5 RESKIT 1 RESKIT 2 PCH-PACLITAXEL 30 PCH-PACLITAXEL 100 PCH-PACLITAXEL 300 A40/2.6.5/0674 SANDOZ SA (PTY) SANDOZ RISPERIDONE 1 A40/2.6.5/0675 SANDOZ SA (PTY) SANDOZ RISPERIDONE 2 A40/2.6.5/0676 SANDOZ SA (PTY) SANDOZ RISPERIDONE 3 A40/2.6.5/0677 SANDOZ SA (PTY) SANDOZ RISPERIDONE 4 A40/2.5/0768 A40/2.5/0769 A40/2.5/0770 S.A. (PTY) S.A. (PTY) S.A. (PTY) 50 mg TABLETS 100 mg TABLETS 200 mg TABLETS Each pre-filled syringe contains: SODIUM HYALURONATE 20,0 mg 250,0 I.U. 500,0 I.U ,0 I.U. TACROLIMUS 0,5 mg 4,0 mg 4,0 mg 4,0 mg RISPERIDONE 0,5 mg RISPERIDONE 1,0 mg RISPERIDONE 2,0 mg RISPERIDONE 1,0 mg RISPERIDONE 2,0 mg RISPERIDONE 3,0 mg RISPERIDONE 4,0 mg LAMOTRIGINE LAMOTRIGINE LAMOTRIGINE 200,0 mg Notification of Aug09v1.doc September 2009 Page 2 of 5
3 Notification of of Medicines 41/7.1.3/0041 S.A. (PTY) 41/5.7.1/0119 GULF DRUG COMPANY (PTY) 41/26/0160 CIPLA LIFE SCIENCES (PTY) 41/26/0161 CIPLA LIFE SCIENCES (PTY) ZYDUS LISINOPRIL/HYDRO- CHLOROTHIAZIDE 20/12,5 mg LORMEG 10 CIPLA-CISPLATIN 10 CIPLA-CISPLATIN 50 LISINOPRIL DIHYDRATE LISINOPRIL 20,0 mg HYDROCHLOROTHIAZIDE 12,5 mg LORATADINE 10,0 mg Each 20,0 ml vial contains: CISPLATIN 10,0 mg Each 50,0 ml vial contains: CISPLATIN 41/21.5.1/0243 PHARMACARE REDIPRED Each 5,0 ml liquid contains: PREDNISOLONE SODIUM PHOSPHATE PREDNISOLONE 15,0 mg 41/7.1.3/0499 AUSTELL 41/7.1.3/0500 AUSTELL 41/7.1.3/0501 AUSTELL 41/7.1.3/0502 AUSTELL 41/7.1.3/0503 AUSTELL 41/7.1.3/0517 AUSTELL 41/7.1.5/0644 ELI LILLY (S.A.) (PTY) 41/7.1.5/0645 ELI LILLY (S.A.) (PTY) 41/7.1/0659 ACCORD HEALTHCARE (PTY) 41/7.1/0660 ACCORD HEALTHCARE (PTY) 41/20.2.8/0808 AUROBINDO PHARMA (PTY) 41/20.2.8/0809 AUROBINDO PHARMA (PTY) AUSTOZAAR 25 AUSTOZAAR 50 AUSTOZAAR 100 LORTELL-25 LORTELL-50 LORTELL-100 CIALIS 5 CIALIS 2,5 AMTAS 5 AMTAS 10 AURO-STAVUDINE 15 mg AURO-STAVUDINE 20 mg TADALAFIL 5,0 mg TADALAFIL 2,5 mg AMLODIPINE BESYLATE AMLODIPINE 5,0 mg AMLODIPINE BESYLATE AMLODIPINE 10,0 mg STAVUDINE 15,0 mg STAVUDINE 20,0 mg 41/30.2/0883 MERCK (PTY) ERBITUX 5 mg/ml CETUXIMAB 5,0 mg Notification of Aug09v1.doc September 2009 Page 3 of 5
4 Notification of of Medicines 41/26/1002 ACCORD HEALTHCARE (PTY) 41/20.1.1/1018 AUSTELL 41/20.1.1/1019 AUSTELL ACCORD VINCRISTINE 1 mg/ml INJECTION AUSTELL 250 mg AUSTELL 500 mg VINCRISTINE SULPHATE 1,0 mg HEMIHYDRATE 2 HEMIHYDRATE 500,0 mg 41/7.1.3/1074 SPECPHARM (PTY) SPEC LOSARTAN 25 : 41/7.1.3/1075 SPECPHARM (PTY) SPEC LOSARTAN /7.1.3/1076 SPECPHARM (PTY) SPEC LOSARTAN 50 41/7.1.3/1077 SPECPHARM (PTY) SPEC LOSARTAN 12,5 12,5 mg 41/26/1095 SANDOZ SA (PTY) LOXAT 30 Each vial contains: PACLITAXEL 30,0 mg 41/26/1096 SANDOZ SA (PTY) LOXAT 100 Each vial contains: PACLITAXEL 41/26/1097 SANDOZ SA (PTY) LOXAT 300 Each vial contains:: PACLITAXEL 300,0 mg 41/2.9/1103 MEDWICH PHARMA (PTY) 41/2.9/1104 MEDWICH PHARMA (PTY) 41/2.9/1105 MEDWICH PHARMA (PTY) 42/30.1/0118 SANOFI-AVENTIS SOUTH AFRICA (PTY) OXYNORM 5 mg OXYNORM 10 mg OXYNORM 20 mg ADACEL QUADRA HYDROCHLORIDE 5,0 mg HYDROCHLORIDE 10,0 mg HYDROCHLORIDE 20,0 mg Each 0,5 dose contains: DIPHTHERIA TOXOID 2,0 Lf PERTUSSIS TOXOID 2,5 µg FILAMENTOUS HAEMAGGLUTININ 5,0 µg FIMBRIAE TYPE 2+3 5,0 µg PERTACTIN 3,0 µg TETANUS TOXOID 5,0 Lf TYPE 1 40 D-antigen units TYPE 2 8 D-antigen units TYPE 3 32 D-antigen units Notification of Aug09v1.doc September 2009 Page 4 of 5
5 Notification of of Medicines 42/26/0132 SANDOZ SA (PTY) SANDOZ VINORELBINE 10 mg/1 ml 42/26/0133 SANDOZ SA (PTY) SANDOZ VINORELBINE 50 mg/5 ml Each vial contains: VINORELBINE 10,0 mg Each vial contains: VINORELBINE 42/26/0134 SANDOZ SA (PTY) NEUVEL 10 mg/1 ml Each vial contains: VINORELBINE 10,0 mg 42/26/0135 SANDOZ SA (PTY) NEUVEL 50 mg/5 ml Each vial contains: VINORELBINE 42/5.7.1/0143 PHARMACARE ASPEN CETIRIZINE 1 mg/ml 42/20.2.2/0446 GLENMARK PHARMACEUTICALS SOUTH AFRICA (PTY) GLENMARK TERBINAFINE 250 CETIRIZINE DIHYDROCHLORIDE 1,0 mg TERBINAFINE to TERBINAFINE 2 42/20.1.1/0592 BAYER (PTY) MOXIBAY IV Each 250,0 ml solution contains: to 400,0 mg 42/20.1.1/0593 BAYER (PTY) MOXIBAY TABLETS to 400,0 mg 42/20.1.1/0594 BAYER (PTY) BAYQUIN TABLETS to 400,0 mg 42/20.1.1/0595 BAYER (PTY) BAYQUIN IV Each 250,0 ml solution contains: to 400,0 mg MS MANDISA HELA REGISTRAR OF MEDICINES Notification of Aug09v1.doc September 2009 Page 5 of 5
MEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) A05/11.5/08 A38/20.1.1/0406
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 30/2.10/0392 TEVA TEVA BACLOFEN
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 41/20.1.1/0039 SCP MYLAN
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 07/3.1.2.2/23 NOVARTIS SA
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 36/7.5/0281 PHARMACARE LIMITED
GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$2.00 WINDHOEK - 3 June 2011 No. 4726
GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA N$2.00 WINDHOEK - 3 June 2011 No. 4726 CONTENTS Page GOVERNMENT NOTICE No. 71 Medicines and Related Substances Control Act, 2003: Registration of certain medicines...
MEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 08/3.1.2/14 INGELHEIM A39/34/0605
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 08/5.1/09 INGELHEIM 08/5.1/10
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT 101 OF 1965 Application Number Holder of registration
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT 101 OF 1965 Application Number Holder of registration
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 06/17.1.6/07 AFRIVET LOGISTICS
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 42/2.5/0453 ZYDUS HEALTHCARE
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 47/26/0920 SANOFI-AVENTIS
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 36/20.1.2/0204 BIOTECH 36/20.1.2/0205
GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$4.00 WINDHOEK - 26 July 2011 No. 4761
GOVERNMENT GAZETTE OF THE REPUBLIC OF N$4.00 WINDHOEK - 26 July 2011 No. 4761 CONTENTS Page GOVERNMENT NOTICE No. 122 Registration of certain medicines: Medicines and Related Substances Control Act, 2003...
MEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT 101 OF 1965 Application Number Holder of registration
COMMERCIAL APIs. S. No Molecule Name Therapeutic Category USDMF EDMF CEP IH
1 Abacavir Sulphate Antiretroviral - * - 2 Abiraterone Acetate Oncology - - - 3 Albendazole Anti-infective - - - 4 Albuterol Sulphate Respiratory - - 5 Alendronate Sodium Trihydrate Metabolic Disorder
ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS
SR. NO 1 ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS Paracetamol 500 mg, Phenylephrine HCL 5 mg With Chlorpheniramine Maleate 2 mg & Caffeine 30 mg Tablets 2 Salbutamol Tablets BP 2 mg 3 Salbutamol Tablets
PORTFOLIO Q June 2014 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/5
Abiraterone Tablet 250 mg Q4 2015 Acetylsalicylic Acid Tablet GR 100 mg Available Aciclovir Cream 5% - 2 Grs Q4 2014 Alendronic Acid Tablet 70 mg Available Amisulpride Tablet 50 ; 100 ; 200 ; 400 mg Available
Medicines availability short-term supply issues Last updated 01/05/18
Short-term supply issues This resource includes availability information on medicines that are reported to have supply issues, with next expected availability within the next three months. This list is
Kern Pharma Portfolio 2014
Kern Pharma Portfolio 2014 DOSSIERS DEVELOPED DURING 2013-2014 ARIPIPRAZOL (ODT) 10mg, 15mg tablets CHONDROITIN SULPHATE 400mg capsules ( well established use ) DEXKETOPROFEN TROMETAMOL 25mg, tablets DULOXETIN
Subject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013
Subject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013 Sl. No. F.No. Name of the Company/ Formulation Date of receipt of application
TLS HEALTH Product list up-dated 2017 (Origin: Portugal)
TLS HEALTH Product list up-dated 2017 (Origin: Portugal) 1 Alendronic acid 70 mg tablet 4 units 2 Amlodipine 10 mg tablet 20,60 units 3 Amlodipine 5 mg tablet 20,60 units 5 Aripiprazole 10 mg tablet 14,
Iraq NDI Iraq 04-J India 05-AH France Famar Lyon France 05-D UNITED ARAB EMIRATES. Iraqi Biocon Limited Indian 06-AA0-001
nam origmanufacturer nammanufacturer National code Mousel Scientific Iraq NDI Iraq 04-J00-042 Sandoz GmbH Austria for Sandoz GmbH by Sandoz Ilac Sanayi ve India 05-AH0-040 France Famar Lyon France 05-D00-024
BabyJabs Vaccines. All vaccines are mercury-free We use aluminium-free vaccines wherever possible
BabyJabs Vaccines All vaccines are mercury-free We use aluminium-free vaccines wherever possible BabyJabs is a dedicated children s immunisation service, offering a choice of single and small combination
ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced
ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced Class Medicine Name Nappi Strength Form Size Route Abiraterone Acetate ZYTIGA
BabyJabs Vaccines. All vaccines are mercury-free We use aluminium-free vaccines wherever possible
BabyJabs Vaccines All vaccines are mercury-free We use aluminium-free vaccines wherever possible BabyJabs is a dedicated children s immunisation service, offering a choice of single and small combination
Riesbeck's Pharmacy Reward Club Generic Medication List October 2017
Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Inj 50MG/ML 1 3 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml
Riesbeck's Pharmacy Reward Club Generic Medication List September 2017
Drug Category Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Riesbeck's Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml 2160ml Hydroxyzine
NIT 97 - APPROVED DRUG LIST
1 EDL0422 Name of the and Strength Chlorine based compound NADCC Tablets 75 mg With Available Chloroine 45 mg BIS* 1 pack of 1000 tablets VAT 440748 71.0000 74.5500 ADHISH INDUSTRIES 2 120092 Cloxacillin
ACTIVE PHARMACEUTICAL INGREDIENTS (APIs)
ACTIVE PHARMACEUTICAL INGREDIENTS (APIs) Product Paracetamol/ Acetaminophen Ph.Eur & Metformin HCl Hypoglycemic Ph.Eur & Ibuprofen Analgesic Ph.Eur & Guaifenesin Mucolytic Ph.Eur & Muscle relaxant PHARMACEUTICAL
PORTFOLIO Q October 2015 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/6
Abiraterone Tablet 250 mg Q4 2016 Acetylsalicylic Acid Tablet GR 100 mg Available Aciclovir Cream 5% - 2 Grs Available Alendronic Acid Tablet 70 mg Available Amikacin Solution for injection 50 mg/ml; 125mg/ml;
Riesbeck's Pharmacy Reward Club Generic Medication List February 2018 $4 30 Day Supply
Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Inj 50MG/ML 1 3 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml
Product List Finished Dosage Forms (FDF) B2B Business
Product List 2017 Finished Dosage Forms (FDF) B2B Business Anaesthetics Dermatology Lidocaine Lidocaine and Prilocaine Dexmedetomidine Hydrochloride Anti-Infectives Amoxicillin Trihydrate and Potassium
Acetaminophen 500 mg Diphenhydramine HCl 25 mg. Pain Reliever, Nighttime Sleep Aid. counts: 24 Compare to Tylenol Simply Sleep. Naproxen Sodium 220 mg
ANALGESICS Aspirin 81 mg Analgesic Diphenhydramine HCl 25 mg Pain Reliever, Nighttime Ibuprofen USP 200 mg counts: 60, 300(b/o) Compare to Aspirin Regimen Bayer 81 mg counts: 24 Compare to Tylenol Simply
TRIPACEL Pertussis Vaccine-Acellular, Combined with Diphtheria and Tetanus Toxoids (Adsorbed)
TRIPACEL Pertussis Vaccine-Acellular, Combined with Diphtheria and Tetanus Toxoids (Adsorbed) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about TRIPACEL.
UPLB-S , SUPPLY AND DELIVERY OF DRUGS AND MEDICINES TECHNICAL SPECIFICATION FOR THE PUBLIC BIDDING OF: OPENING OF BIDS:
1 1 0.3 Sodium Chloride with 5% Dextrose in 1000 ml in plastic bottle 2 0.3 Sodium Chloride With 5% Dextrose In 500 ml In Plastic Bottle 3 0.9 Sodium Chloride with 5% Dextrose 1000 ml in plastic bottle
Rajasthan Medical Services Corporation Limited, Jaipur
Rajasthan Medical Services Corporation Limited, Jaipur List of Drugs- Purchase order placed to successful Bidders Tendered on 05/07/2011 S.No. Name of Drug 1 Atropine Sulphate Injection 0.6 mg /ml (SC/IM/IV
PRODUCT LIST GENERAL - TABLETS
SR. NO. PRODUCT LIST GENERAL - TABLETS 1 Ciprofloxacin Tablets IP 500 mg 2 Ciprofloxacin And Tinidazole Tablets 3 Cefpodoxime Proxetil Tablets IP 4 Cefixime Dispersible Tablets 200 mg 5 Cefixime Dispersible
Alaska Medicaid 90 Day** Generic Prescription Medication List
1 ACYCLOVIR 200 MG CAPSULE BUPROPION HCL 150 MG TAB ER 24H ACYCLOVIR 200 MG/5ML BUPROPION HCL 150 MG TABLET ER ACYCLOVIR 400 MG TABLET BUPROPION HCL 150 MG TABLET ER ACYCLOVIR 800 MG TABLET BUPROPION HCL
GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$5.60 WINDHOEK - 31 July 2012 No. 5003
GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA N$5.60 WINDHOEK - 31 July 2012 No. 5003 CONTENTS Page GOVERNMENT NOTICES No. 186 Cancellation of certain medicines: Medicines and Related Substances Control
ADACEL POLIO. This leaflet answers some common questions about ADACEL POLIO. It does not take the place of talking to your doctor or pharmacist.
ADACEL POLIO Pertussis Vaccine Acellular and Diphtheria and Tetanus Toxoids (Adsorbed) Combined with Inactivated Poliovirus Type 1,2 and 3 (Vero cell) Consumer Medicine Information What is in this leaflet
BabyJabs Vaccines. All vaccines are mercury- free We use aluminium- free vaccines wherever possible
BabyJabs Vaccines All vaccines are mercury- free We use aluminium- free vaccines wherever possible BabyJabs is a dedicated children s immunisation service, offering a choice of single and small combination
EUROPEAN MEDICINES AGENCY DECISION. of 31 March 2009
European Medicines Agency Doc. Ref. EMEA/160106/2009 P/64/2009 EUROPEAN MEDICINES AGENCY DECISION of 31 March 2009 on the acceptance of a modification of an agreed Paediatric Investigation Plan for Purified
Use of Infanrix -IPV+Hib in the infant primary immunisation schedule
Use of Infanrix -IPV+Hib in the infant primary immunisation schedule An update for registered healthcare practitioners July 2014 Quality Education for a Healthier Scotland 1 Acknowledgments Many thanks
As a result of these reviews, Discovery Health has updated its Chronic Medicine Formulary and CDA.
Dear Pharmacist Update on the CDL formulary and Chronic Drug Amount for 2017 Discovery Health reviews the Chronic Medicine Formulary and Chronic Drug Amounts (CDAs) twice a year. We do this to make sure
New Exception Status Benefits
AUGUST 2017 Nova Scotia Formulary Updates New Exception Status Benefits Forxiga (dapagliflozin) Xigduo (dapagliflozin and metformin hydrochloride) Criteria Update: Antipsychotic Medications Abilify (aripiprazole)
Development of Recombinant Pertussis Vaccines
Development of Recombinant Pertussis Vaccines Wassana Wijagkanalan, PhD BioNet-Asia Co., Ltd, Bangkok, Thailand DCVMN Workshop: Global Registration and Vaccine Shortage 6-10 March 2017, Taipei, Taiwan
ADCO-CAPTOPRIL 25MG BIO-CAPTOPRIL 25MG MERCK-CAPTOPRIL 25MG SANDOZ CAPTOPRIL 25MG ZAPTO 25MG TAB
CHRONIC RENAL FAILURE REGISTRATION CRITERIA: Diagnosis confirmed by a GP or Specialist Faxed copy of lab results required : serum creatinine clearance value
TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 28 February 2014
28 February 2014 TENDER RESULTS PHARMAC has resolved to award tenders for for Sole Subsidised Supply Status and Status for some products included in the Invitation to Tender, dated 07 November 2013. Some
DT Description Price Category Price change
Tariff T Watch October 2014 Readers are no doubt aware of this quarter's bad news for primary care prescribing allocations: NHS England has d the remuneration mechanism for community pharmacies gaining
Information for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs CADUET (amlodipine besylate/atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have
DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M %
June 2016 On 13th May, the DH announced that there would be reductions to Category M prices from June until September. http://psnc.org.uk/our-news/contractor-notice-category-m-price-reduction/ This has
Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference.
Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference. Product Number API Test product Dose/ mg Manufacturer Country of manufacture Country
MABCAMPATH mg 3 INJ GENZYME BIOPHARMACEUTICALS. MABCAMPBATH mg 3 INJ GENZYME BIOPHARMACEUTICALS
ICON Formulary - November 2016 Class Medicine Name Nappi Strength Form Size Route Manufacturer Abiraterone Acetate ZYTIGA 250 720690001 250 mg 120 ORAL JANSSEN PHARMACEUTICALS Aldesleukin CHIRON IL-2 18
DATE OF PRE-BID CONFERENCE: DEADLINE OF SUBMISSION OF BIDS: OPENING OF BIDS:
UHS FC: 8703417 Dr. Marilyn Reaño 1 1 0.3 Sodium Chloride with 5% Dextrose in 1000 ml in plastic 120 btl 70.00 8,400.00 2 0.3 Sodium Chloride With 5% Dextrose In 500 ml In Plastic 240 btl 70.00 16,800.00
Information for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs LIPITOR (atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have the same efficacy or
Pharmacy Savings Program
Pharmacy Savings Program SELECT GENERICS DRUG LIST The Pharmacy Savings Program provides you with savings on select generic medications included on this list. The prices for these select generic medications
Legal Supplement Part B Vol. 57, No. 6 18th January, NOTIFICATION NOTICE OF APPROVAL IN RESPECT OF NEW DRUGS
Legal Supplement Part B Vol. 57, No. 6 18th January, 2018 11 LEGAL NOTICE NO. 5 REPUBLIC OF TRINIDAD AND TOBAGO FOOD AND DRUGS ACT, CHAP. 30:01 NOTIFICATION NOTICE OF APPROVAL IN RESPECT OF NEW DRUGS ISSUED
Packing List SS#: From: HEALTH PARTNERS INTERNATIONAL 2907 PORTLAND DRIVE OAKVILLE ON CANADA L6H 5S4. Ship to: Carrier:
30 907 PORTLAND DRIVE OAKVILLE ON CANADA LH S4 PHONE:(90) 70-990 X FAX:(90) 70-74 ShipDate: /9/ Shipper# PTP30- Bott/0ml 0 TUBE/7G Tube/30g Box/ Box/ Kaopectate OS 70mg/mL, Bottle/0mL 790043 Attapulgite
Table updated 26 th February Salbutamol 26 th February Lofepramine hydrochloride 22 nd February Zoledronic acid 21 st February 2019
This table contains information on shortages of human medicines notified to the Health Products Regulatory Authority that have been resolved in the last 6 months. Table updated 26 th February 2019 Product
Table updated 15 th February Sodium valporate 15 th February Ramipril & Felodipine 15 th February 2019
This table contains information on shortages of human medicines notified to the Health Products Regulatory Authority that have been resolved in the last 6 months. Table updated 15 th February 2019 Product
Published by the Pharmaceutical Services Division to provide information for British Columbia s health care providers
Published by the Pharmaceutical Services Division to provide information for British Columbia s health care providers QuickLinks Keeping the Lines Clear... 1 Newsletter Notification Service... 1 Special
DOSSIER LIST. tlo_seledyn.pdf :38:01 CMY K CM MY CY
tlo_seledyn.pdf 1 22.08.2017 14:38:01 C M Y CM MY CY CMY K DOSSIER LIST tlo_seledyn.pdf 1 22.08.2017 14:38:01 PRODUCT NAME PHARMACEUTICAL FORM STRENGTH REFERENCE THERAPEUTIC CLASS ALIMENTARY TRACT & METABOLISM
Product Name Strength Dosage Form Therapeutic Area Dossier Status. Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved
Product Name Strength Dosage Form Therapeutic Area Dossier Status Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved Alendronate Sodium 10/70mg Tablets Osteoporosis Approved Anastrozole
PBS PRICE INCREASES - AUGUST 2014 SCHEDULE
Price increase review - general PBS benzylpenicillin 600 mg injection, 1 x 600 mg vial 1775K, 3398W, BenPen 3.84 4.38 3486L benzylpenicillin 3 g injection, 1 x 3 g vial 2647H, 3399X, BenPen 6.60 7.55 3487M
While there is around a 3% increase shown in costs for Category M lines, I think this is due to the inclusion of more lines in Category M.
April 2018 The usual quarterly of Category M prices Another set of similar comments as I made in January: significant increases in many lines which have been subject to price concessions but even more
DAPTACEL National Drug Code Directory
49281-286-10 DAPTACEL National Drug Code Directory The Drug Listing Act of 1972 requires registered drug establishments to provide the Food and Drug Administration (FDA) with a current list of all drugs
Tablets, Capsules, Syrup, Dry syrup, Suspensions, Lotions and food products.
Renewed Life sciences - A WHO-GMP Complaint plant situated in pollution free atmosphere and lush green environment of Haridwar, Uttrakhand, Incorporated to pursue an ambitious goal of producing specialized
List of changes in Out-Patients Formulary
List of changes in Out-Patients Formulary Change in prescriber criteria Alpha Tocopheryl (Vitamin E) suspension 100mg/mL, tablets 50-150mg, tablets 670mg Atorvastatin tablets Bezafibrate tablets 400mg
CONTACT POLPHARMA GROUP POLPHARMA B2B
DOSSIER FDFLIST Product name Pharmaceutical form Strength Reference Therapeutic class ALIMENTARY TRACT & METABOLISM 1. Esomeprazole sodium or injection 40 mg Nexium / AstraZeneca Antiulcerant 2. Omeprazole
Immunisation Subcommittee of PTAC Meeting held 28 October 2015
Immunisation Subcommittee of PTAC Meeting held 28 October 2015 (minutes for web publishing) Immunisation Subcommittee minutes are published in accordance with the Terms of Reference for the Pharmacology
AUSTRALIAN PRODUCT INFORMATION
AUSTRALIAN PRODUCT INFORMATION NAME OF THE MEDICINE ADACEL Pertussis Vaccine-Acellular Combined with Diphtheria and Tetanus Toxoids (Adsorbed) DESCRIPTION ADACEL is a sterile, uniform, cloudy, white suspension
+91-8048718516 Proton Pharma Private Limited http://www.protonpharma.in/ We are one of the leading manufacturer and distributors of high quality Medicines. Owing to highest level of quality standards,
Care at the Chemist. Formulary
Care at the Chemist Formulary 1 Acute bacterial conjunctivitis Chloramphenicol 0.5% eye drops (10ml) For ages 2 years and over. Chloramphenicol 1% eye oint. (4g) For ages 2 years and over. Allergy Loratadine
MRP Monthly Update MRP 12/2013
Monthly Update 12/2013 13/12/2013 Mediscor Reference Price - Notification Effective Date: 1 January 2014 Dear Vendors and Colleagues, The files for January 2014 are now available on our website: www.mediscor.net/mrp.html
Diphtheria-Tetanus-Acellular Pertussis-Polio- Combined Vaccine Biological Page (DTaP-IPV)
Diphtheria-Tetanus-Acellular Pertussis-Polio- Combined Vaccine Biological Page (DTaP-IPV) Section 7: Biological Product Information Standard #: 07.212 Created by: Province-wide Immunization Program Standards
Care at the Chemist. Formulary
Care at the Chemist Formulary 1 Acute bacterial conjunctivitis Chloramphenicol 0.5% eye drops (10ml) Chloramphenicol 1% eye oint. (4g) Allergy Loratadine 10mg tablets (7) Sodium cromoglycate 2% eye drops
Product List Rusan Pharma Ltd.
A Technology Driven Enterprise Product List Rusan Pharma Ltd. TABLETS 1 Amitriptyline Tablets Amitriptyline (As Hydrochloride) 10 / 5mg 00 Amlodipine Tablets Amlodipine (As Besylate) 5 / 10mg N 30 3 Atorvastatin
What s New
What s New 23.12.2016 NPPA has fixed/revised ceiling prices of 55 scheduled formulations of Schedule-I under Drugs ( Control) Amendment Order,2016 and Retail of 29 formulations under DPCO, 2013 in related
Information for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs ZOLOFT (sertraline hydrochloride) tablets, for oral use This list does not imply that the products on this chart are interchangeable or have the
CONTRACT UPDATE July 20, 2012
CONTRACT UP July 20, 2012 ADDS AMPHETAMINE SALT MIX ER CAPSULE 10MG 100 002-3059-11 $422.45 ACTAVIS ADDS AMPHETAMINE SALT MIX ER CAPSULE 20MG 100 002-3060-11 $422.45 ACTAVIS ADDS AMPHETAMINE SALT MIX ER
TEPZZ A_T EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (51) Int Cl.: A61K 9/00 ( ) A61K 9/20 (2006.
(19) TEPZZ 96746A_T (11) EP 2 96 746 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: 13.01.16 Bulletin 16/02 (1) Int Cl.: A61K 9/00 (06.01) A61K 9/ (06.01) (21) Application number: 102377.1
Diphtheria-Tetanus-Acellular Pertussis-Polio- Haemophilus influenzae type b Conjugate Combined Vaccine Biological Page (DTaP-IPV-Hib)
Diphtheria-Tetanus-Acellular Pertussis-Polio- Haemophilus influenzae type b Conjugate Combined Vaccine Biological Page (DTaP-IPV-Hib) Section 7: Biological Product Information Standard #: 07.211 Created
CONTRACT UPDATE June 15, 2012
CONTRACT UP June 15, 2012 ADDS HYDRALAZINE INJECTION 20MG/ML 1MLX25 17478-0934-15 $143.03 AKORN 06-15-2012 12-31-2013 178739 10106085 ADDS BENZONATATE CAPSULE 100MG 100 65162-0536-10 $9.95 AMNEAL PHARMACEUTICALS
Approved USP Compounded Monographs
APPROVED USP COMPOUNDED MONOGRAPHS Acacia Syrup Acetazolamide Oral Suspension Acetylcysteine Compounded Solution Diluted Acetic Acid Diluted Alcohol Allopurinol Oral Suspension Alprazolam Oral Suspension
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES PUBLISHED AUGUST 2016 There is growing distrust of pharma in light of several recent and dramatic
Pharmaceuticals and Medical Devices. Safety Information
Safety Information No. 244 February 2008 Table of Contents 1. Revision of PRECAUTIONS (No. 194) GEM-Premier 3000 PAK and 10 others 3 2. List of products subject to Early Post-marketing Phase Vigilance
Anti Infectives. Product Generic Name Dosage Form Strength Available Pack Sizes. Powder for Oral Suspension
Product Disclaimer Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk. Product
PHARMA LIMITED (NIGERIA)
FROM DIRECTORS DESK At Savocent we believe that "Quality is not an act but it is a habit." Savocent is dedicated to meet the needs of customers through discovering, developing, manufacturing & marketing
Pharmaceuticals and Medical Devices Safety Information
Pharmaceuticals and Medical Devices Safety Information No. 248 July 2008 Table of Contents 1. Revision of PRECAUTIONS (No. 198) (1) Bepridil Hydrochloride (and 1 other) 3 2. List of products subject to
ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Rosuvastatin + Clopidogrel Capsule (Crevast CV 20)
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of Pharmaceuticals National Pharmaceutical
DATA SHEET. 1. PRODUCT NAME (strength pharmaceutical form)
DATA SHEET 1. PRODUCT NAME (strength pharmaceutical form) ADACEL POLIO 0.5 ml suspension for injection Pertussis Vaccine - Acellular and Diphtheria and Tetanus Toxoids (Adsorbed) Combined with Inactivated
PEDIACEL. Intramuscular injection. Suspension for injection. DESCRIPTION
PEDIACEL Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine and Haemophilus b Conjugate Vaccine (Tetanus Protein - Conjugate) Intramuscular
List of Products Approved By Drugs Control Organization, Jaipur Sr. No. Name of Product Tablets Biological
List of Products Approved By Drugs Control Organization, Jaipur Sr. No. Name of Product Tablets Biological 1 Vitamin B Complex Tablets N.F.I.( Therapeutic) 2 Vitamin B Complex Tablets N.F.I. (Prophylactic)
Product Selection Committee / Comité de sélection des produits
New Brunswick Pharmaceutical Society and New Brunswick Department of Health Product Selection Committee / Comité de sélection des produits L Ordre des pharmaciens P.O. Box / C.P. 5100, Fredericton NB E3B